Immunotherapy & Immuno-oncology

PART OF NEXTGEN BIOMED 2025

12 - 14 March 2025 | London, UK

Programme Summary

A carefully curated event packed with leading speakers, research and cutting-edge presentations on the latest advancements in the discovery & development of novel immunotherapies; advances in cellular, antibody and combination therapy development as well as personalised cancer therapy treatments.

Hear from past attendees of last year's Biologics 2024 conference

What's New for 2025?

Gain valuable insights into advancing immunotherapy strategies to treat cancer & autoimmune diseases. Presentations will cover the current immunotherapy strategies, latest innovations in cancer immunotherapy, cytokine therapies & anti T cell therapies.

Discover the microbiome & the gut immune axis. Take a deep dive into understanding the relationship between the microbiome and cancer to transform immune-modulating therapies; the role of microbiota in metabolisms & immunity as well as novel technologies for microbiome analysis.

Hear from opinion leaders on personalised cancer therapies. Hear about advancements in cancer vaccine development, vaccines for non-infectious diseases and neoantigen identification strategies.

Explore predictive models & tools for preclinical evaluation and translational development. Thought-leaders will be discussing humanized and 3D models, maximizing translatability through effective in vitro and in vivo models and the role of the tumour microenvironment in ensuring clinical success.

NextGen Biomed - What to Expect Poster 2
NextGen Biomed - What to Expect Exhibiting 2
NextGen Biomed - What to Expect Networking 5
1000

leading pharma, biotech, regulatory & academic delegates

700
pre-arranged 1-2-1 meetings, facilitating business growth
50
hours of presentations, discussions & interactive content
12
hours of networking breaks, including fireside chats & refreshments

Agenda at a Glance

Immunotherapy & Immuno-oncology

DAY ONE - 12 MARCH

Track 7: Discovery & Development: Cell & Gene and Combination Therapies
Track 8: Biomarkers, ctDNA, Precision Medicine & Multi-Omics In Immuno-Oncology

DAY TWO - 13 MARCH

Track 7: Immunotherapy Strategies & Development
Track 8: Predictive Models & Tools for Preclinical Evaluation and Translational Development

DAY THREE - 14 MARCH

Track 7: Personalised Cancer Therapies
Track 8: Novel Targets in Immuno-oncology: Identification, Validation & Exploration

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

Interested in NextGen Biomed 2025?